Yuankai Shi

13.2k citations
312 papers · 6.0k · 2 hit papers · h-index 36

Impact in

  • Oncology top 0.5%
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Lung Cancer Research Studies 81
    • Colorectal Cancer Treatments and Studies 41
    • Viral-associated cancers and disorders 28
    • Cancer Immunotherapy and Biomarkers 27
    • Lung Cancer Treatments and Mutations 132
    • Lung Cancer Diagnosis and Treatment 48

Yuankai Shi

288 papers receiving 6.0k citations

Yuankai Shi's Hit Papers

Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial 2019 · 265 citations
2650+4+8Years since publication2505007501000

Peers

Yuankai Shi
Comparison fields: 5 of 128
  • Oncology 3.5k
  • Pulmonary and Respiratory Medicine 2.9k
  • Cancer Research 1.0k
  • Pathology and Forensic Medicine 1.1k
  • Genetics 364
Replace Roberto Bianco with:
Roberto Bianco Italy
Junji Tsurutani Japan
Mark F. Brady United States
Marie Wislez France
Srinivasan Madhusudan United Kingdom
Daniele Generali Italy
Michael Millward Australia
Makoto Tahara Japan
Helen Mackay Canada
Jean‐Pierre Delord France
Yuankai Shi relative to Roberto Bianco Italy Roberto Bianco's profile →
Citations per field
00.5×1.5×1.8×
Roberto Bianco · 1×
Citations per year

Countries citing papers authored by Yuankai Shi

Since Specialization
Citations

This map shows the geographic impact of Yuankai Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuankai Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuankai Shi more than expected).

Fields of papers citing papers by Yuankai Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuankai Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuankai Shi. The network helps show where Yuankai Shi may publish in the future.

Co-authors

The 25 scholars most cited alongside Yuankai Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuankai Shi Line = papers co-authored together Yuankai Shi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 312 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)
Hit paper breakdown →
20141105
2
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial
Hit paper breakdown →
2019265
3 2007218
4 2018195
5 2020181
6 2015139
7 2008138
8 2018137
9 2012135
10 2008121
11 200597
12 201487
13 201383
14 201782
15 201581
16 200776
17 201976
18 201874
19 201769
20 200868

About Yuankai Shi

Yuankai Shi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Molecular Biology and Cancer Research, having authored 312 papers that have together received 6.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (132 papers), Lung Cancer Research Studies (81 papers), Lymphoma Diagnosis and Treatment (71 papers), Lung Cancer Diagnosis and Treatment (48 papers), Colorectal Cancer Treatments and Studies (41 papers), Cancer Genomics and Diagnostics (30 papers), Viral-associated cancers and disorders (28 papers) and Cancer Immunotherapy and Biomarkers (27 papers). The work is most often cited by research in Oncology (3.5k citations), Pulmonary and Respiratory Medicine (2.9k citations), Cancer Research (1.0k citations), Pathology and Forensic Medicine (1.1k citations) and Genetics (364 citations). Yuankai Shi has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Xiaohong Han, Pan‐Chyr Yang, Chun‐Ming Tsai, Sumitra Thongprasert, Y. Itoh, Gerardo Cornelio, Mai Trong Khoa, Joseph S. K. Au, Sankar Srinivasan and Peng Liu. Their work appears in journals such as Journal of Clinical Oncology, Blood, Journal of Thoracic Oncology, Annals of Oncology and Cancer Immunology Immunotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact